![Christiane Proll](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Volker Pfahlert | M | 66 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 14 years |
Gerhard Ries | M | 55 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Kathy L. Bates | F | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 5 years |
Bernhard Schirmers | M | 70 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Gregory F. Heath | M | 66 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 2 years |
Claus Botzler | M | 59 |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Philipp Pagel | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | 13 years |
Rainer Kutzner | M | - |
numares AG
![]() numares AG Medical SpecialtiesHealth Technology numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christiane Proll
- Personal Network